XANDRA
GARCÍA GONZÁLEZ
Profesora asociada de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (15)
2023
-
Hacia la excelencia en la atención farmacéutica al paciente quirúrgico
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30
-
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology, Vol. 13
-
Presence of metallic components in transdermal drug delivery systems and risk of skin burns
Farmacia Hospitalaria
2022
-
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494
-
Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy
Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1287.e9-1287.e15
2021
-
Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients
International Journal of Clinical Pharmacy, Vol. 43, Núm. 3, pp. 731-736
-
Valganciclovir—Ganciclovir use and systematic therapeutic drug monitoring. An invitation to antiviral stewardship
Antibiotics, Vol. 10, Núm. 1, pp. 1-18
2019
-
Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”
Pharmacological Research
-
Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution
International Journal of Antimicrobial Agents, Vol. 53, Núm. 1, pp. 40-48
-
Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin
Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 3, pp. 694-698
2018
-
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Annals of Hematology, Vol. 97, Núm. 11, pp. 2089-2098
2017
-
Systematic therapeutic drug monitoring for linezolid: Variability and clinical impact
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 10
2016
-
Efficiency of biological therapies in patients with moderate to severe psoriasis: Impact of a pharmacotherapeutic protocol
Journal of Dermatological Treatment, Vol. 27, Núm. 3, pp. 198-202
-
Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome
Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 1, pp. 59-63
2015
-
Coste-efectividad y seguridad de telaprevir y boceprevir para el tratamiento de la hepatitis C crónica en la práctica clínica
Gastroenterologia y Hepatologia, Vol. 38, Núm. 10, pp. 575-582